OOIR: Observatory of International Research

Papers

(The TQCC of Microbes and Infection is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2	149
Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster	144
Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes	138
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses	129
Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses	108
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study	94
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement	93
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients	93
Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency	81
Could nasal nitric oxide help to mitigate the severity of COVID-19?	67
Arbidol/IFN-α2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study	66
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season	63
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis	55
Molecular basis of COVID-19 relationships in different species: a one health perspective	54
Bacterial and fungal co-infections among COVID-19 patients in intensive care unit	53
Anti-science extremism in America: escalating and globalizing	45
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China	40
Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19	40
COVID19 meets the antivaccine movement	39
Current development of COVID-19 diagnostics, vaccines and therapeutics	37
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development	37
Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants	35
Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types	35
Pneumonia caused by Mycobacterium tuberculosis	30
NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity	27

Impact of non-pharmaceutical interventions during the COVID-19 pandemic on common childhood respiratory viruses – An epidemiological study based on hospital data	24
Prolonged viral shedding and antibody persistence in patients with COVID-19	23
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system	22
Therapeutic approaches for combating Pseudomonas aeruginosa infections	20
Cause or effect? The spatial organization of pathogens and the gut microbiota in disease	19
Does the hygiene hypothesis apply to COVID-19 susceptibility?	19
Management of COVID-19: current status and future prospects	18
The intestinal microbiota: from health to disease, and back	17
Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis	17
Chloroquine paradox may cause more damage than help fight COVID-19	17
Detection of Mayaro virus in Aedes aegypti mosquitoes circulating in Goiânia-Goiás-Brazil	17
The metaeffector MesI regulates the activity of the Legionella effector SidI through direct protein–protein interactions	16
The Pseudomonas aeruginosa HSP90-like protein HtpG regulates IL-8 expression through NF-κB/p38 MAPK and CYLD signaling triggered by TLR4 and CD91	16
Digging the rabbit hole, COVID-19 edition: anti-vaccine themes and the discourse around COVID-19	16
It is too soon to attribute ADE to COVID-19	15
Pathogenesis and immune response in Brucella infection acquired by the respiratory route	14
Combination of colistin and tobramycin inhibits persistence of Acinetobacter baumannii by membrane hyperpolarization and down-regulation of efflux pumps	14
Transcriptional ups and downs: patterns of gene expression in the life cycle of Toxoplasma gondii	14
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)	14
Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19	14
COVID-19 vaccine decisions: considering the choices and opportunities	14
Unraveling Ascaris suum experimental infection in humans	14
Coronavirus vaccine-associated lung immunopathology-what is the significance?	14
Machine learning-based investigation of the relationship between gut microbiome and obesity status	13
Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis	13
Characterization of reduced susceptibility to chlorhexidine among Gram-negative bacteria	12
Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis	12
Anti-malarial humoral immunity: the long and short of it	12
Increased IL-8 levels in HIV-infected individuals who initiated ART with CD4+ T cell counts <350 cells/mm3 – A potential hallmark of chronic inflammation	12
Increased susceptibility to Mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes	12
Retrograde axonal transport property of adeno-associated virus and its possible application in future	12
Patient-derived Enterococcus mundtii and its capsular polysaccharides cause depression through the downregulation of NF-κB-involved serotonin and BDNF expression	12
Porphyromonas gingivalis in oral squamous cell carcinoma: a review	11
COVID-19 and Fungal infections: a double debacle	11
The COVID-19 epidemic and other notifiable infectious diseases in China	11
The fate of house cats during the COVID-19 pandemic	11
Dihydromyricetin is a new inhibitor of influenza polymerase PB2 subunit and influenza-induced inflammation	11
Comparative proteomics in the three major human pathogenic species of the genus Sporothrix	11
The Forrest Gump approach to preventing severe COVID-19 – reverse the predisposing pro-inflammatory state with exercise	10
BFRF1 protein is involved in EBV-mediated autophagy manipulation	10
SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector	10
Chlamydia psittaci in fulmars on the Faroe Islands: a causative link to South American psittacines eight decades after a severe epidemic	9
Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis	9
Recurrence of COVID-19 after recovery ? A case series in health care workers, France	9
COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France)	9
The immunopathogenesis of tuberculous pericarditis	9
Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection	9
N-acetyl-cysteine mediates protection against Mycobacterium avium through induction of human β-defensin-2 in a mouse lung infection model	9
Staphylococcus epidermidis small colony variants, clinically significant quiescent threats for patients with prosthetic joint infection	8
Could targeting immunometabolism be a way to control the burden of COVID-19 infection?	8

Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection	8
The microbiota protects against Pseudomonas aeruginosa pneumonia via γδ T cell-neutrophil axis in mice	8
Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals	8
A metagenomic study of the gut microbiome in PTB’S disease	8
Substantial induction of non-apoptotic CD4 T-cell death during the early phase of HIV-1 infection in a humanized mouse model	8
The attenuation of Th1 and Th17 responses via autophagy protects against methicillin-resistant Staphylococcus aureus-induced sepsis	7
Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients	7
COVID-19: disease, or no disease? - that is the question. It’s the dose stupid!	7
Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines	7
Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2	7
Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo	7
Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19	7
Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering	7
Modulation of human endogenous retroviruses –H, -W and -K transcription by microbes	7
Lycopene attenuates Staphylococcus aureus-induced inflammation via inhibiting α-hemolysin expression	7
Deceiving the big eaters: Salmonella Typhimurium SopB subverts host cell xenophagy in macrophages via dual mechanisms	7
Application experience of a rapid nucleic acid detection system for COVID-19	7
Airborne infection with Covid-19? A historical look at a current controversy	7
Defined gut microbial communities: promising tools to understand and combat disease	7
Messages from the Fourth International Conference on Clinical Metagenomics	7
CD38 deficiency up-regulated IL-1β and MCP-1 through TLR4/ERK/NF-κB pathway in sepsis pulmonary injury	7
Galactosaminogalactan secreted from Aspergillus fumigatus and Aspergillus flavus induces platelet activation	7
Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza	7
Nanomotion technology in combination with machine learning: a new approach for a rapid antibiotic susceptibility test for Mycobacterium tuberculosis	7
The prebiotic effect of human milk oligosaccharides 3′- and 6′-sialyllactose on adhesion and biofilm formation by Clostridioides difficile – pilot study	7
Effects of IgG and IgM autoantibodies on non-infected erythrocytes is related to ABO blood group in Plasmodium vivax malaria and is associated with anemia	7
Regulatory T cells in acute and chronic human Chikungunya infection	7
Characterization of Brucella abortus S19 as a challenge strain for use in a mouse model of brucellosis	7
Therapeutic potential of kaempferol on Streptococcus pneumoniae infection	6
Clinical and genomic data of sars-cov-2 detected in maternal–fetal interface during the first wave of infection in Brazil	6
Xanthenedione (and intermediates involved in their synthesis) inhibit Zika virus migration to the central nervous system in murine neonatal models	6
Availability of essential diagnostics at primary care public clinics in Peru	6
Sendai virus V protein decreases nitric oxide production by inhibiting RIG-I signaling in infected RAW264.7 macrophages	6
Emergency response to the outbreak of COVID-19: the Korean case	6
Biogenic silver nanoparticles reduce Toxoplasma gondii infection and proliferation in RAW 264.7 macrophages by inducing tumor necrosis factor-alpha and reactive oxygen species production in the cells	6
TREM-1 enhances Mycobacterium tuberculosis-induced inflammatory responses in macrophages	6
A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice	6
Dirty mice join the immunologist's toolkit	6
Characteristics of in vitro infection of human monocytes, by Rickettsia helvetica	6
Novel H7N7 avian influenza viruses detected in migratory wild birds in eastern China between 2018 and 2020	6
Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii	6
Hypoxia promotes Chlamydia trachomatis L2/434/Bu growth in immortal human epithelial cells via activation of the PI3K-AKT pathway and maintenance of a balanced NAD+/NADH ratio	6